SynDevRx has filed a notice of an exempt offering of securities to raise $29,354,820.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, SynDevRx is raising up to $29,354,820.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Brad Carver played…
